論文・技術情報追加のお知らせ

①Dipeptidyl Peptidase 4 Inhibitors and Gallbladder or Biliary Diseases: Data From the U.S. Food and Drug Administration Adverse Event Reporting System.

DDP-4阻害剤と胆嚢,胆道疾患との関連調査

対象DB：FAERS

②Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system.

多発性骨髄腫患者における免疫調整薬安全性調査研究

対象DB：FAERS

③Vaccine Vigilance System: Considerations on the Effectiveness of Vigilance Data Use in COVID-19 Vaccination.

ワクチンビジランスシステム・データ活用の効果考察

対象DB：EudraVigilance

④Post-Marketing Surveillance of Statins-A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance.

スタチンに関連する精神科的副作用調査

対象DB：EudraVigilance

⑤Cardiac adverse events in bisphosphonate and teriparatide users: An international pharmacovigilance study.

ビスフォスフォネートおよびテリパラチド使用者における心臓の有害事象調査

対象DB：VigiBase

⑥Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review.

小児および青年におけるクロザピン誘発性心筋炎のファーマコビジランス研究

対象DB：VigiBase